Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous nucleus pulposus cell transplantation is an autologous cell therapy being investigated for the treatment of lumbar intervertebral disc herniation. The procedure involves harvesting nucleus pulposus cells from a patient's herniated disc material during a primary surgical excision, followed by the re-implantation of these cells back into the disc space. The goal is to regenerate the disc's structural integrity and biological function by replenishing the cell population responsible for maintaining the extracellular matrix. This specific program was evaluated in a clinical study at the Navy General Hospital in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous nucleus pulposus cell transplantation.